BVAXF
Price:
$0.1559
Market Cap:
$6.12M
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research c...[Read more]
Industry
Biotechnology
IPO Date
2018-12-28
Stock Exchange
OTC
Ticker
BVAXF
According to BioVaxys Technology Corp.’s latest financial reports and current stock price. The company's current ROE is 380.38%. This represents a change of 108.82% compared to the average of 182.16% of the last 4 quarters.
The mean historical ROE of BioVaxys Technology Corp. over the last ten years is 278.58%. The current 380.38% ROE has changed 36.54% with respect to the historical average. Over the past ten years (40 quarters), BVAXF's ROE was at its highest in in the October 2022 quarter at 1.10%. The ROE was at its lowest in in the July 2020 quarter at -380.55%.
Average
278.58%
Median
205.97%
Minimum
-121.04%
Maximum
1.52%
Discovering the peaks and valleys of BioVaxys Technology Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 542.89%
Maximum Annual ROE = 1.52%
Minimum Annual Increase = -2019.60%
Minimum Annual ROE = -121.04%
| Year | ROE | Change |
|---|---|---|
| 2024 | 205.97% | -9.65% |
| 2023 | 227.97% | -84.96% |
| 2022 | 1.52% | -2019.60% |
| 2021 | -78.98% | 542.89% |
| 2020 | -12.29% | -89.85% |
| 2019 | -121.04% | -157.00% |
The current ROE of BioVaxys Technology Corp. (BVAXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
650.01%
5-year avg
371.75%
10-year avg
278.58%
BioVaxys Technology Corp.’s ROE is less than Futura Medical plc (15.42%), less than Burzynski Research Institute, Inc. (2.59%), less than Kane Biotech Inc. (211.08%), less than Theralink Technologies, Inc. (147.47%), less than MYND Life Sciences Inc. (35.68%), less than Bioxytran, Inc. (84.19%), greater than ProText Mobility, Inc. (0%), less than Curative Biotechnology, Inc. (65.29%), less than Lobe Sciences Ltd. (141.08%), less than BioCorRx Inc. (33.00%),
| Company | ROE | Market cap |
|---|---|---|
| 15.42% | $6.10M | |
| 2.59% | $5.78M | |
| 211.08% | $4.16M | |
| 147.47% | $615.15K | |
| 35.68% | $1.71M | |
| 84.19% | $6.69M | |
| 0% | $9.11M | |
| 65.29% | $8.07M | |
| 141.08% | $579.60K | |
| 33.00% | $6.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVaxys Technology Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioVaxys Technology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioVaxys Technology Corp.'s ROE?
How is the ROE calculated for BioVaxys Technology Corp. (BVAXF)?
What is the highest ROE for BioVaxys Technology Corp. (BVAXF)?
What is the 3-year average ROE for BioVaxys Technology Corp. (BVAXF)?
What is the 5-year average ROE for BioVaxys Technology Corp. (BVAXF)?
How does the current ROE for BioVaxys Technology Corp. (BVAXF) compare to its historical average?